Effectiveness of Semaglutide in Overweight or Obese Patients With IgA Nephropathy Without Diabetes

All data of this study are available from the corresponding author upon reasonable request. Data S1. Supplementary Methods. Table S1. The clinical and pathological characteristics of eight patients with IgAN. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.